Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Zhong

Showing results (911-920 of 940) with videos related to

Pageof 94
Sort By:
Nature Communications|October 4, 2023
Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinomaChunyang Bao, Richard W Tourdot, Gregory J Brunette, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 29, 2024
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8<sup>+</sup> T cell functionYujia Liu, Lixiang Wang, Yiyi Li, et al.
World Journal of Gastroenterology|December 12, 2003
Relationship between clinical and pathologic findings in patients with chronic liver diseasesLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 27, 2004
[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial]Lun-gen Lu, Min-de Zeng, Yi-min Mao, et al.
Nature Biotechnology|November 20, 2003
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteriaXiao-Qing Qiu, He Wang, Xiao-Fong Lu, et al.
Science Immunology|June 13, 2025
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearanceCheng Zhong, Lixiang Wang, Yujia Liu, et al.
Hepatology (Baltimore, Md.)|November 25, 2014
The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis BLiang Peng, Qiang Zhao, Qibin Li, et al.
Blood Advances|January 26, 2021
DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromesKensuke Kayamori, Yurie Nagai, Cheng Zhong, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinomaMingkee Achom, Ananthan Sadagopan, Chunyang Bao, et al.
World Journal of Gastroenterology|October 16, 2004
Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical studyYi-Min Mao, Min-De Zeng, Lun-Gen Lu, et al.
Pageof 94

Showing results (911-920 of 940) with videos related to

Sort By:
Pageof 94
Nature Communications|October 4, 2023
Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinomaChunyang Bao, Richard W Tourdot, Gregory J Brunette, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 29, 2024
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8<sup>+</sup> T cell functionYujia Liu, Lixiang Wang, Yiyi Li, et al.
World Journal of Gastroenterology|December 12, 2003
Relationship between clinical and pathologic findings in patients with chronic liver diseasesLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 27, 2004
[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial]Lun-gen Lu, Min-de Zeng, Yi-min Mao, et al.
Nature Biotechnology|November 20, 2003
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteriaXiao-Qing Qiu, He Wang, Xiao-Fong Lu, et al.
Science Immunology|June 13, 2025
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearanceCheng Zhong, Lixiang Wang, Yujia Liu, et al.
Hepatology (Baltimore, Md.)|November 25, 2014
The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis BLiang Peng, Qiang Zhao, Qibin Li, et al.
Blood Advances|January 26, 2021
DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromesKensuke Kayamori, Yurie Nagai, Cheng Zhong, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinomaMingkee Achom, Ananthan Sadagopan, Chunyang Bao, et al.
World Journal of Gastroenterology|October 16, 2004
Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical studyYi-Min Mao, Min-De Zeng, Lun-Gen Lu, et al.
Pageof 94